SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers
about
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dotshZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancerNa(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCTChanges in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axesNew trends in molecular and cellular biomarker discovery for colorectal cancerSLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanismsEndogenous voltage gradients as mediators of cell-cell communication: strategies for investigating bioelectrical signals during pattern formationThyroid iodide efflux: a team effort?Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal CancerGut microbiota-derived short-chain Fatty acids, T cells, and inflammationFunctional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acidsAssociation of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancerResistant starch: promise for improving human healthUsing rule-based machine learning for candidate disease gene prioritization and sample classification of cancer gene expression dataMapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma.Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.Cancer genes hypermethylated in human embryonic stem cells.Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.Genomic and epigenetic instability in colorectal cancer pathogenesis.Role of monocarboxylate transporters in drug delivery to the brain.Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomasBioenergetic characterization of mouse podocytes.Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.A CpG island methylator phenotype of colorectal cancer that is contiguous with conventional adenomas, but not serrated polyps.Genome-wide screening of genes regulated by DNA methylation in colon cancer development.Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate.Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressivenessSystematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes.Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice.Overexpression of tumor suppressor protein OSCP1/NOR1 induces ER stress and apoptosis during development of Drosophila melanogaster.DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas.Epigenetics and colorectal cancerEpigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
P2860
Q21093286-EFD8BB6D-306F-40D4-9E8E-C1EFA3E20C85Q24530662-6545BE8E-6BA3-4B6C-ACBC-63FF5C1E6758Q24545763-508AEFF8-9514-47DE-A023-26CA8F712562Q24810345-C10ED15E-0F35-403D-AE83-E20358FF20EBQ26739049-F193145D-2766-4407-948C-4F7E1EDDE2E8Q26749468-EB46A67B-EA58-4DE4-85F1-6A0A6174D926Q26851654-AABB414A-A0C0-45B0-BF00-DC87A6AB7D6BQ26865962-EBE77CC4-CD6F-4B97-9289-C39CD3C604D3Q28077783-87D95D66-2C7D-4623-A7B0-8D9FA277D6D9Q28084903-03D1425D-85EF-4EBD-8994-97015F1C1DF7Q28245395-17C40375-BC0F-401C-807A-CCAD85413332Q28253304-D69F10E2-2EA1-465F-98A2-BCB898A50125Q28301879-B72866F7-596E-4006-AF00-4189CF2DF8D9Q28386273-783CA2FA-3590-4636-91FF-2E65E0663F94Q30437438-4AA6CFBC-3360-418A-B918-E4FEC1202AF0Q30481256-4CEA7142-D73E-44DA-AC2B-5905EAE59DAFQ30491686-A73FCE11-4119-4740-9C96-FD8313DD1CA2Q33372334-07A3C4D2-4A30-41EE-83AC-1FA5E1159C33Q33641532-AEA3064A-D923-4B10-9DB7-6AB355BFEC50Q33662455-D38EF61A-F91A-46EB-ABBE-E9717D111AA4Q33836026-02CBFCA1-5BC0-45FA-A7D5-E0D99BFFA6BAQ33854710-D4C4CC6C-3970-403E-A7C4-651A4577BA39Q33916825-23DFD90B-3047-4ED3-A673-647103190D03Q33936814-F99F486F-1C36-43DD-8020-8BC3EB2D7C94Q34085737-70452768-CE38-4F0C-9348-204E3222BEBFQ34269623-28458E2E-81B3-4A7B-A6DC-38EB0CB4B28AQ34293192-2C981040-768C-4EE2-9458-F74C5CB66C91Q34437619-633D117F-AE5D-4784-B7BB-13D352949507Q34487177-27725AD1-F2BE-4C3D-A3E6-17C910171261Q34563854-F16D29CE-6D29-4DFB-AA28-4CA48507FA01Q34710990-2DEB391E-96AE-4FB0-AFBC-EC0A9867C5EFQ35118915-D9E044AB-27FA-40C1-BCB5-2B648AC5E37CQ35300832-B2BB2801-B73B-4E0E-A169-E31E2AA2C397Q35489763-D4E4A11E-4A42-42F6-8F37-0C3CE9B327E5Q35676728-94250F06-B7CD-46CC-9986-DE5FF5A08D3EQ35835232-35943D26-BAE3-4EEE-894A-43B1AA1A79C4Q35878544-1B5B9EA6-C07F-4F64-9E73-9E5317750F73Q36081553-372B49AB-A60E-414C-9E1F-46816D005832Q36085799-117CAE7F-E0C9-4425-B2C3-1A391D1B10F2Q36086546-3DA407A8-8491-4A5D-A459-CD6E308B7416
P2860
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@ast
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@en
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@nl
type
label
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@ast
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@en
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@nl
prefLabel
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@ast
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@en
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@nl
P2093
P2860
P3181
P356
P1476
SLC5A8, a sodium transporter, ...... berrant crypt foci and cancers
@en
P2093
Christoph Plass
Dominic Smiraglia
James K V Willson
James Lutterbaugh
Jean-Pierre Issa
Joseph Willis
Lakshmi Kasturi
Lois Myeroff
Michael F Romero
P2860
P304
P3181
P356
10.1073/PNAS.1430846100
P407
P50
P577
2003-07-08T00:00:00Z